Back to Search
Start Over
Intellipharmaceutics Announces Start of Intranasal Human Abuse Liability Studies for Oxycodone ER Updated on 08-05-2018
- Source :
- Plus Company Updates. May 9, 2018
- Publication Year :
- 2018
-
Abstract
- Toronto: Intellipharmaceutics International Inc has issued the following news release: Intellipharmaceutics International Inc. (NASDAQ and TSX: IPCI) ('Intellipharmaceutics' or the 'Company'), a pharmaceutical company specializing in the research, development and [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.537941678